Naivex (DOLUTEGRAVIR 50 mg) x 30 Tablets

Generic Dolutegravir 50 mg Price in Other Currencies

Uses of DOLUTEGRAVIR 50 mg

• Treats HIV-1 infection in adults and eligible children.
• Used in combination with other antiretroviral medicines.
• Helps reduce the amount of HIV in the body.
• Slows the progression of HIV infection.
• Supports long-term HIV management.

Benefits of DOLUTEGRAVIR 50 mg

• Effectively suppresses HIV replication.
• Helps increase and maintain CD4 (immune) cell counts.
• Reduces the risk of HIV-related infections.
• Lowers viral load to undetectable levels in many patients.
• Has a high barrier to drug resistance.
• Convenient once-daily oral tablet.
• Supports long-term viral suppression.
• Helps strengthen the immune system.
• Improves quality of life with regular treatment.
• Can be combined with various HIV treatment regimens.

How Does It Work?

Dolutegravir is an integrase strand transfer inhibitor (INSTI). It works by blocking the HIV integrase enzyme, which the virus needs to insert its genetic material into human immune cells. This prevents HIV from multiplying, reduces the viral load, and helps protect and strengthen the immune system.

Precautions

• Take the medicine exactly as prescribed by your doctor.
• Do not stop treatment without medical advice.
• Inform your doctor if you have liver disease or hepatitis B or C infection.
• Regular blood tests may be required during treatment.
• Inform your doctor about all medicines, vitamins, and herbal supplements you are taking.
• Take antacids or calcium/iron supplements only as directed, as they may reduce the medicine’s effectiveness.
• Use during pregnancy or breastfeeding only if advised by your doctor.
• Practice safe measures to reduce the risk of HIV transmission.
• Take the tablet at the same time each day.
• Attend regular follow-up appointments to monitor viral load and immune function.

Side Effects

• Headache and dizziness
• Insomnia or trouble sleeping
• Nausea or diarrhea
• Fatigue or low energy
• Possible liver function changes (monitoring recommended)